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Epinephrine inhibits insulin release by activation of K+ channels and subsequent hyperpolarization
of pancreatic beta cells. The present study explored whether epinephrine-induced hyperpolarization
is modiﬁed by phosphatidylinositol 3-kinase (PI3K) and phosphatidylinositide-dependent kinase
PDK1. Perforated patch-clamp was performed in islet cells isolated from PDK1 hypomorphic mice
(pdk1ﬂ/ﬂ), expressing only 20% of PDK1, and in their wild-type littermates. At 16.8 mM glucose, the
cell membrane was hyperpolarized by epinephrine (1 lM), an effect signiﬁcantly blunted in
pdk1ﬂ/ﬂ and abrogated in wild-type cells by inhibition of PI3K with wortmannin (100 nM) or
LY294002 (10 lM). The hyperpolarizing effect of epinephrine in pancreatic islet cells is thus sensitive
to PI3K and PDK1.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Insulin release from pancreatic islet cells is inhibited by epi-
nephrine via activation of a2-adrenoceptors [1,2]. Epinephrine is
at least partially effective through activation of K+ channels, subse-
quent hyperpolarization of the cell membrane, inhibition of volt-
age gated Ca2+ channels and decrease of cytosolic Ca2+ activity
[2–4]. The signaling linking receptor activation to altered channel
activity has, however, remained incompletely understood.
Effects of epinephrine in other cell types have been shown to in-
volve phosphatidylinositol 3-kinase (PI3K) [5,6]. PI3K dependent
signaling includes the phosphoinositide-dependent kinase PDK1
[7–13].
The present study explored whether the effect of epinephrine
on cell membrane potential is modiﬁed by inhibition of the PI3K
with the unrelated PI3K inhibitors (LY294002) 2-(4-morpholi-
nyl)-8-phenyl-4H-1-benzopyran-4-one [14,15] and wortmannin
[16]. To deﬁne the contribution of PDK1, gene targeted mice have
been analyzed. As PDK1 knockout mice are not viable [17], exper-
iments have been performed in PDK1 hypomorphic mice (pdk1ﬂ/ﬂ)
expressing only some 20% of PDK1 activity compared to their wild-
type littermates (pdk1+/+) [17].chemical Societies. Published by E
tal calf serum; HEPES, N-2-
294002, PI3K inhibitor; PI3K,
Lang).2. Materials and methods
Phosphoinositide-dependent kinase-1 hypomorphic mice
(pdk1ﬂ/ﬂ) and pdk1+/+ littermates with mixed C57/Bl-6/sv129j back-
ground, 3–6 months old and sex and age matched were kindly pro-
vided by D. Alessi (Biocenter, Dundee, GB) [17]. The pdk1ﬂ/ﬂ mice
express 10–25% of PDK1 and are viable while mice completely
lacking functional PDK1 are not viable [17]. For the experiments
shown in Fig. 1 wild-type mice of C57/BL6 background were used.
All animal experiments were conducted according to the German
law for the care and use of laboratory animals and were approved
by local authorities.
For culture of pancreatic islet cells, the mice were killed by
inhalation of CO2. Digestion of pancreatic tissue was initiated by
retroverse injection of 3 ml collagenase solution containing 1 mg/
ml collagenase (Serva, Heidelberg, Germany) into the bile duct.
The pancreas was cut out from other adjacent organs and tissues.
Collagenase digestion was performed for 10 min at 37 C in a water
bath and terminated by addition of 30 ml ice-cold Hank’s solution.
Thereafter the pancreatic fragments were sedimented by centrifu-
gation (150 g for 1 min at RT). White islets were isolated from exo-
crine tissue under a dissection microscope by hand selection.
The puriﬁed islets were resuspended in sterile 10 ml ice-cold
PBS (Ca2+/Mg2+-free, pH 7.2, Gibco) and a single cell preparation
obtained by digestion of islets with trypsin (0.025% in PBS) as
described previously [18]. Isolated islet cells were resuspended
in culture medium at a concentration of 50 islets/100 ll andlsevier B.V. All rights reserved.
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Fig. 1. PI3K inhibitors counteract the hyperpolarizing effect of epinephrine on the islet cell membrane. (A) Original tracing illustrating the cell membrane potential in an islet
cell from a wild-type mouse of C57/BL6 background. The experiments have been performed prior to and following an increase of extracellular glucose concentration to
16.8 mM, subsequent addition and then washing-out of 1 lM epinephrine. (B) Original tracing of the cell membrane potential following an increase of extracellular glucose
concentration to 16.8 mM and subsequent addition of LY294002 (10 lM). (C) Original tracing of the cell membrane potential following an addition of ﬁrst LY294002 (10 lM)
and then epinephrine (1 lM). (D) Original tracing of the cell membrane potential following an increase of extracellular glucose concentration to 16.8 mM and subsequent
addition of wortmannin (100 nM). (E) Original tracing of the cell membrane potential following an addition of ﬁrst wortmannin (100 nM) and then epinephrine (1 lM). (F)
Cell membrane potential (±S.E.M., n = 7–16) at 16.8 mM glucose concentration measured before (control, white bars) and after application of either epinephrine (1 lM), or
LY294002 (10 lM) or wortmannin (100 nM) as well as after application of epinephrine on top of either LY294002 or wortmannin. *** indicates signiﬁcant difference from
control from epinephrine (ANOVA, P < 0.001).
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grown in RPMI 1640 supplemented with 10% (v/v) fetal calf serum
(FCS), 10 mM N-2-hydroxyethylpiperazine-N0-2-ethanesulfonic
acid (HEPES), 1 mM Na-pyruvate, 2 mM L-glutamine, 50 i.u. peni-
cillin/ml and 50 lg streptomycin/ml. About 8–10 dishes were pre-
pared from 100 islets. Cells were kept in an incubator 1–3 days
before the experiments.
Epinephrine, LY294002 hydrochloride and wortmannin (pur-
chased from Sigma–Aldrich, Deisenhofen, Germany) were applied
at the indicated concentrations to the bath solution. The sub-
stances were prepared as aliquots and stored in 20 C up to 2
months before use.
For patch-clamp experiments, the culture dish with attached
primary mouse islet cells was mounted onto the stage of an in-
verted microscope. The volume of the recording chamber was0.2–0.3 ml. The bath solution containing in mM 145 NaCl, 5 KCl,
1 MgCl2, 2.5 CaCl2, 10 HEPES and 5.6 glucose (pH 7.4) was super-
fused into the chamber at a rate of 5–6 ml/min. The experiments
were carried out at room temperature (20 C). Experiments were
performed using perforated whole-cell current clamp recording
to monitor membrane potential by use of an EPC9 patch-clamp
ampliﬁer (HEKA Electronic Company, Germany). Patch pipettes
were pulled from borosilicate glass capillaries (GC150TF-7.5,
1.5 mm O.D.  1.17 mm I.D. Harvard Apparatus Ltd., UK) and
heat-polished using a DMZ universal puller (Zeitz, Augsburg, Ger-
many). Pipettes had a resistance of 4.0–6.0 MX when ﬁlled with
the internal solution containing in mM: 95 K-Gluconate, 30 KCl, 1
MgCl2, 3 EGTA, 1 CaCl2, 1.2 NaH2PO4 and 4.8 Na2HPO4 (pH 7.3).
The pipette solution contained amphotericin B (1 mg/ml pipette
solution prepared just before use and protected from light). After
Y. Zhang et al. / FEBS Letters 583 (2009) 3101–3106 3103formation of a cell-attached conﬁguration, perforated whole-cell
conﬁguration was formed within 5–10 min. Only stable voltage
measurements were used for analysis, i.e. when the access resis-
tance was stable and lower than 20 MX.
Data are presented as means ± S.E.M. for the indicated number
of cells examined. ANOVA and Student’s paired t-test were used
for statistical analysis, as appropriate. P values <0.05 were accepted
to indicate statistical signiﬁcance.
3. Results
In control islet cells from wild-type mice the increase of extra-
cellular glucose concentration from 5.6 mM to 16.8 mM signiﬁ-
cantly (P < 0.001) depolarized the cell membrane (from
55.16 ± 1.15 mV at 5.6 mM glucose to 38.82 ± 1.07 mV within
62.6 ± 6.9 s following an increase to 16.8 mM (n = 38)) and trig-
gered action potentials reﬂecting opening of Ca2+ channels
(Fig. 1A). About 22% of the islet cells did not respond with cell
membrane depolarization and appearance of action potentials
upon increasing glucose concentration in the bath. Those cells
were not used for the following experiment. Most probably, 78%
cells represent beta cells, whereas the other 22% represent other
types of islet cells. The distribution of the different islet cell types
may be variable depending on culture conditions [19]. Application
of epinephrine (1 lM) in the continued presence of 16.8 mM glu-
cose resulted in a signiﬁcant (P < 0.001) hyperpolarization of the
cell membrane to 55.2 ± 1.4 mV (n = 16; Fig. 1A and F). The
hyperpolarizing effect of epinephrine was observed in each of theB
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Fig. 2. PI3K inhibitors lead to recovery of the islet cell membrane potential after epineph
of extracellular glucose concentration to 16.8 mM, subsequent addition of 1 lM epineph
an islet cell from a wild-type mouse of C57/BL6 background. (B) Original tracing of the cel
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C57/BL6 background.16 recordings performed, started approximately 10–15 s after its
application and reached a maximal value within some 20–30 s.
After removal of epinephrine the membrane potential reversed
within 1–5 min in 12 out of 16 recordings completely to a potential
of 38.6 ± 2.0 mV (n = 12, Fig. 1A).
Application of the LY294002 (10 lM; n = 7) prior to epinephrine
did not signiﬁcantly (P = 0.086) modify the cell membrane poten-
tial (Fig. 1B) but prevented the epinephrine-induced hyperpolar-
ization (LY294002 alone 40.0 ± 2.1 mV vs. LY294002 plus
epinephrine 42.1 ± 2.8 mV; n = 7 respectively; Fig. 1C and F).
Application of wortmannin, another inhibitor of PI3K (100 nM)
was similarly without signiﬁcant effect on the membrane potential
in the absence of epinephrine (Fig. 1D), but prevented the epineph-
rine-induced hyperpolarization (wortmannin 45.7 ± 3.6 mV vs.
wortmannin plus epinephrine 48.8 ± 3.7 mV; n = 7; P = 0.08;
Fig. 1E and F). In the presence of wortmannin, but not of
LY294002, epinephrine reduced the action potential frequency
(Fig. 1E). The frequency was 1.8 ± 0.4 action potentials/s in the
presence of wortmannin and 0.5 ± 0.1 action potentials/s in the
presence of wortmannin + epinephrine (analyzed utilizing 70–
80 s recordings in four independent experiments; P < 0.05). In
experiments, when the cells were ﬁrst treated with epinephrine
to induce hyperpolarization, application of LY294002 or wortman-
nin resulted in subsequent depolarization and reappearance of ac-
tion potentials (Fig. 2). In the presence of epinephrine the
membrane potential increased from 46.7 ± 3.7 mV to
38.7 ± 3.6 mV after addition of LY294002 and to 32.1 ± 3.5 mV
following addition of wortmannin (n = 3, P < 0.05).ose
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Fig. 3. Effect of epinephrine on the cell membrane potential in islet cells from PDK1 wild-type and hypomorphic mice. (A) Original tracing of the cell membrane potential
following an increase of extracellular glucose concentration to 16.8 mM, subsequent addition and then washing-out of 1 lM epinephrine in an islet cell from a PDK1 wild-
type mouse (pdk1+/+, C57/Bl-6/sv129j background). (B) Original tracing of the cell membrane potential following an increase of extracellular glucose concentration to
16.8 mM and subsequent addition of 1 lM epinephrine in an islet cell from a PDK1 hypomorphic mouse (pdk1ﬂ/ﬂ). (C) Cell membrane potential (±S.E.M., n = 5–7 cells from
three mice in each group) at 16.8 mM glucose concentration in the absence or in the presence of 1 lM epinephrine in islet cells from either pdk1+/+ or pdk1ﬂ/ﬂ mice. * indicates
signiﬁcant difference from control pdk1+/+ (ANOVA, P 6 0.05).
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pdk1+/+ mouse islet cells (Fig. 3A and C) but was abrogated in islet
cells from PDK1 hypomorphic mice (pdk1ﬂ/ﬂ) (Fig. 3B). The expo-
sure of the cells to 16.8 mM glucose and 1 lM epinephrine resulted
in a signiﬁcant (P < 0.05) hyperpolarization from 40.3 ± 3.6 mV to
53.4 ± 3.2 mV (n = 5 cells from three mice) in pdk1+/+ mouse islet
cells (Fig. 3A and C). In contrast, as shown in Fig. 3B and C the
application of epinephrine (1 lM) in the presence of 16.8 mM glu-
cose did not signiﬁcantly (P = 0.11) hyperpolarize pdk1ﬂ/ﬂ mouse is-
let cells (41.5 ± 1.4 mV prior to and 44.6 ± 2.3 mV following
epinephrine, n = 7 cells from three mice).
4. Discussion
The present study demonstrates that the hyperpolarizing effect
of epinephrine in pancreatic islet cells is abrogated by two unre-
lated inhibitors of the PI3K and is signiﬁcantly blunted in mice
with decreased expression of PDK1. Effects of LY294002 on K+
channels have been demonstrated in insulin secreting cells at a
concentration of 50 lM, in the present study LY294002 was used
at a ﬁve times lower concentration and the similar inhibitory effect
of wortmannin and the blunted hyperpolarizing effect of epineph-
rine in PDK1 hypomorphic mice strongly suggest a mechanism
dependent on PI3K and PDK1 signaling [20]. As a matter of fact,
PI3K and PDK1 have previously been shown to upregulate voltage
gated K+ channels [10]. The reduction of action potential frequency
by epinephrine in the presence of wortmannin and in PDK1 deﬁ-
cient cells suggests that epinephrine not only activates K+ channels
but may also inhibit Ca2+ channels independent of PI3K activity. Aninhibition of those channels has been observed in several cells
including pancreatic beta cells [21].
Earlier studies revealed that in mice epinephrine-induced
hyperpolarization is not due to opening of KATP channels [22]. This
observation was conﬁrmed using mouse islet cells deﬁcient in
functional KATP channels [4]. A study with speciﬁc K+ channel
inhibitors suggested that epinephrine activated inwardly rectifying
potassium (GIRK) channels that are sensitive to high concentra-
tions of tertiapin-Q [23]. In insulin secreting cells from rat and
hamster, epinephrine seems to act through the activation of KATP
channels, as tolbutamide counteracted the hyperpolarizing effect
of epinephrine [24,25]. The opening of KATP channels by leptin
has been shown to depend on PI3K signaling that is dependent
on PTEN and actin reorganisation [26,27].
Since the epinephrine induced hyperpolarization is mimicked
by speciﬁc alpha2 adrenoceptor agonists and abolished by pertus-
sis toxin pretreatment, the effect is obviously mediated by alpha2
adrenoceptor activation coupled to Gi/Go proteins [2,25,28,29]. In
other cell types, involvement of PI3K in the signaling of a-adrener-
gic receptors and G proteins has been demonstrated [6,30,31]. As
wortmannin has been shown to deplete cellular PIP2 pools [32]
and GIRK channel activity depends on PIP2, it seems likely that epi-
nephrine is unable to open GIRK channels in cells depleted of PIP2
due to treatment with wortmannin. Whether epinephrine activates
GIRK channels by increasing PIP2 or through another mechanism
remains to be elucidated [33,34].
Epinephrine and somatostatin have been found to inhibit glu-
cose-dependent augmentation of insulin mRNA [35]. This observa-
tion may be explained by the recent ﬁnding that epinephrine
Y. Zhang et al. / FEBS Letters 583 (2009) 3101–3106 3105inhibits glucose-mediated stimulation of ERK1/2 in insulin secret-
ing cells, an effect of epinephrine which is sensitive to pertussis
toxin [36].
The present study did not deﬁne the signaling pathway down-
stream of PDK1. PI3K/PDK1 dependent signaling involves protein
kinase B (PKB/Akt) and SGK isoforms [11,13,37–39]. Both SGK
[38] and PKB/Akt [40] have previously been shown to regulate K+
channels. Moreover, SGK1 has previously been shown to account
for the upregulation of Kv1.5 K+ channels in pancreatic beta cells
by dexamethasone [18]. Without stimulation by dexamethasone,
the expression level of SGK1 is, however, low in pancreatic beta
cells [18] and thus, SGK1 probably does not account for the ob-
served PI3K/PDK1 dependent hyperpolarization. The possibility
must be kept in mind that PDK1may be active without PI3K signal-
ing and that pharmacological inhibition of PI3K may thus not com-
pletely disrupt PDK1 dependent signaling.
Galanin and somatostatin, similar to epinephrine, inhibit insulin
release, whereby they apparently utilize a distinct receptor but a
similar mechanism [3]. Future experiments may reveal whether
or not galanin and somatostatin similarly act though activation
of the PI3K pathway. However, it should be noted that inhibition
of insulin secretion by epinephrine but also by somatostatin may
imply mechanisms unrelated to ion channel activity [41]. The pres-
ent paper does not rule out PI3K dependence or independence of
those additional adrenergic effects.
The PDK1 deﬁciency of the pdk1ﬂ/ﬂ mouse does not only affect
the electrophysiology of the pancreatic islet cells but impairs insu-
lin dependent regulation of PKB, S6K and RSK [17]. Moreover,
intestinal and renal electrogenic glucose transport is signiﬁcantly
decreased in those mice [42]. The alterations of plasma glucose
concentration following an intrapertitoneal glucose load are, how-
ever, not signiﬁcantly different between pdk1+/+ and pdk1ﬂ/ﬂ mice
[42].
In conclusion, the epinephrine induced hyperpolarization of
pancreatic islet cells depends on the activation of PI3K and PDK1.
The present observations thus disclose a novel mechanism in the
regulation of pancreatic K+ channels which may be important not
only for the hyperpolarizing effects of epinephrine but for electro-
physiological effects of other hormones and growth factors known
to signal through the PI3K pathway.
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